open access

Ahead of print
Case report
Published online: 2021-05-05
Get Citation

Pancreatectomy as a form of treatment for leiomyosarcoma metastasis to pancreas — case report and literature review

Martyna Różewicz, Joanna Pełka, Jakub Pałucki, Małgorzata Lenarcik, Sławomir Falkowski, Tomasz Olesiński
DOI: 10.5603/OCP.2021.0016

open access

Ahead of print
CASE REPORTS
Published online: 2021-05-05

Abstract

Background: Pancreatic cancers represent about 2% of all malignant tumors. The prognosis for patients is rather poor and the five-year survival is only 9%. Metastases constitute 2–5% of this organ’s tumors, and the management of such cases is determined individually depending on the type of cancer, the patient’s condition and the medical center’s experience. We present a rare case of pancreatic metastasis from a subcutaneous leiomyosarcoma.

Case: A 71-year-old woman with history of leiomyosarcoma — six years ago, two cancer outbreaks, located in the subcutaneous tissue of the thigh and shoulder treated by surgery and adjuvant radiotherapy. After 5 years, a lung metastasis was diagnosed and successfully resected. The following year, CT scan revealed a mass in the pancreas. The patient also complained of epigastric pain and bloating. The biopsy of the lesion confirmed leiomyosarcoma metastasis. The patient underwent 6 cycles of ADIC chemotherapy, after which the tumor size decreased and the laparotomy was performed. The metastasis was well-demarcated and did not infiltrate surrounding tissues, so distal pancreatectomy provided a complete tumor resection There were no complications throughout surgery During 12 months follow up no recurrence was observed.

Conclusions: Due to the relatively rare occurrence, standards for the treatment of pancreatic metastases have not been developed yet. This case shows that treatment by resection of the tumor while maintaining a surgical margin can be considered as a form of treatment in pancreatic secondary cancers.

Abstract

Background: Pancreatic cancers represent about 2% of all malignant tumors. The prognosis for patients is rather poor and the five-year survival is only 9%. Metastases constitute 2–5% of this organ’s tumors, and the management of such cases is determined individually depending on the type of cancer, the patient’s condition and the medical center’s experience. We present a rare case of pancreatic metastasis from a subcutaneous leiomyosarcoma.

Case: A 71-year-old woman with history of leiomyosarcoma — six years ago, two cancer outbreaks, located in the subcutaneous tissue of the thigh and shoulder treated by surgery and adjuvant radiotherapy. After 5 years, a lung metastasis was diagnosed and successfully resected. The following year, CT scan revealed a mass in the pancreas. The patient also complained of epigastric pain and bloating. The biopsy of the lesion confirmed leiomyosarcoma metastasis. The patient underwent 6 cycles of ADIC chemotherapy, after which the tumor size decreased and the laparotomy was performed. The metastasis was well-demarcated and did not infiltrate surrounding tissues, so distal pancreatectomy provided a complete tumor resection There were no complications throughout surgery During 12 months follow up no recurrence was observed.

Conclusions: Due to the relatively rare occurrence, standards for the treatment of pancreatic metastases have not been developed yet. This case shows that treatment by resection of the tumor while maintaining a surgical margin can be considered as a form of treatment in pancreatic secondary cancers.

Get Citation

Keywords

leiomyosarcoma; pancreatectomy; pancreatic metastasis

About this article
Title

Pancreatectomy as a form of treatment for leiomyosarcoma metastasis to pancreas — case report and literature review

Journal

Oncology in Clinical Practice

Issue

Ahead of print

Article type

Case report

Published online

2021-05-05

DOI

10.5603/OCP.2021.0016

Keywords

leiomyosarcoma
pancreatectomy
pancreatic metastasis

Authors

Martyna Różewicz
Joanna Pełka
Jakub Pałucki
Małgorzata Lenarcik
Sławomir Falkowski
Tomasz Olesiński

References (7)
  1. Istl AC, Ruck JM, Morris CD, et al. Call for improved design and reporting in soft tissue sarcoma studies: A systematic review and meta-analysis of chemotherapy and survival outcomes in resectable STS. J Surg Oncol. 2019; 119(7): 824–835.
  2. van Cann T, Cornillie J, Wozniak A, et al. Retrospective Analysis of Outcome of Patients with Metastatic Leiomyosarcoma in a Tertiary Referral Center. Oncol Res Treat. 2018; 41(4): 206–213.
  3. Reddy S, Wolfgang CL. The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol. 2009; 10(3): 287–293.
  4. Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019; 10(1): 10–27.
  5. Yuasa T, Inoshita N, Saiura A, et al. Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer. 2015; 15: 46.
  6. Serrano C, George S. Leiomyosarcoma. Hematol Oncol Clin North Am. 2013; 27(5): 957–974.
  7. Madkhali AA, Shin SH, Song KiB, et al. Pancreatectomy for a secondary metastasis to the pancreas: A single-institution experience. Medicine (Baltimore). 2018; 97(42): e12653.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl